Apathy is found in almost 80 per cent of late-stage cancer patients. A new study, conducted on mice reveals that apathy is ...

A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in ...

New research from CSHL, WashU Medicine and their collaborators reveals a circuit in the brainstem that can sense inflammation ...

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal ...

Cachexia not only contributes to reduced quality of life but also limits a patient’s ability to tolerate or benefit from ...

Advanced cancer often leads to cachexia, a syndrome causing profound apathy in patients. New research reveals that cancer hijacks brain circuits controlling motivation, suggesting potential treatments ...

This loss of motivation doesn’t just deepen patients’ suffering, it isolates them from family and friends. Because patients ...

In the trial, patients are dosed with B07 as they begin ... "Since there is no FDA approved therapeutic for cancer cachexia, this trial is a crucial step to provide a therapy for an area of ...

A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in ...

This symptom is part of a syndrome called cachexia, which affects about 80% of late-stage cancer patients, leading to severe muscle wasting and weight loss that leave patients bone thin despite ...